Baptiste Elie

Baptiste Elie

Auto-generated profile, based on publicly available information

Baptiste Elie

MIVEGEC, Univ Montpellier, CNRS, IRD, Montpellier, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Epidemics
Verified
Journal Article
Open access
MSMircea T. Sofonea
Mircea T. Sofonea
BRBastien Reyné
Bastien Reyné
BEBaptiste Elie
Baptiste Elie
RDRamsès Djidjou-Demasse
Ramsès Djidjou-Demasse
CSChristian Selinger
Christian Selinger
SASamuel Alizon
Samuel Alizon
SARS-CoV-2 virus has spread over the world rapidly creating one of the largest pandemics ever. The absence of immunity, presymptomatic transmission, and the relatively high level of virulence of the COVID-19 infection led to a massive flow of patients in intensive care units (ICU). This unprecedented situation calls for rapid and accurate mathematical models to best inform public health policies.

24 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
MSMircea T. Sofonea
Mircea T. Sofonea
BRBastien Reyné
Bastien Reyné
BEBaptiste Elie
Baptiste Elie
RDRamsès Djidjou-Demasse
Ramsès Djidjou-Demasse
CSChristian Selinger
Christian Selinger
SASamuel Alizon
Samuel Alizon
SARS-Cov-2 virus has spread over the world creating one of the fastest pandemics ever. The absence of immunity, asymptomatic transmission, and the relatively high level of virulence of the COVID-19 infection it causes led to a massive flow of patients in intensive care units (ICU). This unprecedented situation calls for rapid and accurate mathematical models to best inform public health policies. We develop an original parsimonious model that accounts for the effect of the age of infection on the natural history of the disease. Analysing the ongoing COVID-19 in France, we estimate the value of the key epidemiological parameters, such as the basic reproduction number , and the efficiency of the national control strategy. We then use our deterministic model to explore several scenarios posterior to lock-down lifting and compare the efficiency of non pharmaceutical interventions (NPI) described in the literature.

4 May 2022 in Proceedings Of The Royal Society B-Biological Sciences
Verified
Journal Article
Open access
BEBaptiste Elie
Baptiste Elie
CSChristian Selinger
Christian Selinger
SASamuel Alizon
Samuel Alizon
There is known heterogeneity between individuals in infectious disease transmission patterns. The source of this heterogeneity is thought to affect epidemiological dynamics but studies tend not to control for the overall heterogeneity in the number of secondary cases caused by an infection. To explore the role of individual variation in infection duration and transmission rate in parasite emergence and spread, while controlling for this potential bias, we simulate stochastic outbreaks with and without parasite evolution. As expected, heterogeneity in the number of secondary cases decreases the probability of outbreak emergence. Furthermore, for epidemics that do emerge, assuming more realistic infection duration distributions leads to faster outbreaks and higher epidemic peaks. When parasites require adaptive mutations to cause large epidemics, the impact of heterogeneity depends on the underlying evolutionary model. If emergence relies on within-host evolution, decreasing the infection duration variance decreases the probability of emergence. These results underline the importance of accounting for realistic distributions of transmission rates to anticipate the effect of individual heterogeneity on epidemiological dynamics.

5 May 2022 in Journal of Medical Virology
Verified
Journal Article
Closed access
BEBaptiste Elie
Baptiste Elie
BRBénédicte Roquebert
Bénédicte Roquebert
MSMircea T. Sofonea
Mircea T. Sofonea
STSabine Trombert‐Paolantoni
Sabine Trombert‐Paolantoni
VFVincent Foulongne
Vincent Foulongne
SASamuel Alizon
Samuel Alizon

12 March 2025 in Peer Community Journal
Verified
Journal Article
Open access
PDF file
TKTsukushi Kamiya
Tsukushi Kamiya
NTNicolas Tessandier
Nicolas Tessandier
BEBaptiste Elie
Baptiste Elie
CBClaire Bernat
Claire Bernat
VBVanina Boué
Vanina Boué
SASamuel Alizon
Samuel Alizon
The vaginal microbiota is known to affect women's health. Yet, there is a notable paucity of high-resolution follow-up studies lasting several months, which would be required to interrogate the long-term dynamics and associations with demographic and behavioural covariates. Here, we present a high-resolution longitudinal cohort study of 125 women, followed for a median duration of 8.6 months, with a median of 11 samples collected per woman. Using a hierarchical Bayesian Markov model, we characterised the patterns of vaginal microbiota community persistence and transition, simultaneously estimated the impact of 16 covariates and quantified individual variability among women. We showed that “optimal” (Community State Type (CST) I, II, and V) and “sub-optimal” (CST III) communities are more stable over time than “non-optimal” (CST IV) ones. Furthermore, we found that some covariates — most notably alcohol consumption — impacted the probability of shifting from one CST to another. We performed counterfactual simulations to confirm that alterations of key covariates, such as alcohol consumption, could shape the prevalence of different microbiota communities in the population. Finally, our analyses indicated that there is a relatively canalised pathway leading to the deterioration of vaginal microbiota communities, whereas the paths to recovery can be highly individualised among women. In addition to providing one of the first insights into vaginal microbiota dynamics over a year, our study showcases a novel application of a hierarchical Bayesian Markov model to clinical cohort data with many covariates. Our findings pave the way for an improved mechanistic understanding of microbial dynamics in the vaginal environment and the development of novel preventative and therapeutic strategies to improve vaginal health.

4 June 2020 in medRxiv
Verified
Preprint
Open access
PDF file
GDGonché Danesh
Gonché Danesh
BEBaptiste Elie
Baptiste Elie
YMYannis Michalakis
Yannis Michalakis
MSMircea T. Sofonea
Mircea T. Sofonea
ABAntonin BAL
Antonin BAL
SASamuel Alizon
Samuel Alizon
France was one of the first countries to be reached by the COVID-19 pandemic. Here, we analyse 196 SARS-Cov-2 genomes collected between Jan 24 and Mar 24 2020, and perform a phylodynamics analysis. In particular, we analyse the doubling time, reproduction number ( ℛ t ) and infection duration associated with the epidemic wave that was detected in incidence data starting from Feb 27. Different models suggest a slowing down of the epidemic in Mar, which would be consistent with the implementation of the national lock-down on Mar 17. The inferred distributions for the effective infection duration and ℛ t are in line with those estimated from contact tracing data. Finally, based on the available sequence data, we estimate that the French epidemic wave originated between mid-Jan and early Feb. Overall, this analysis shows the potential to use sequence genomic data to inform public health decisions in an epidemic crisis context and calls for further analyses with denser sampling.